NFKB1 and cancer: TNFSF15, a member of the tumour necrosis factor ligand superfamily, modulates inflammatory disorders and MAPK/NF-κB/PI3K signalling pathway. Alteration in this pathway leads to many diseases condition including cancer, autoimmune disorders, etc. [34] (Table 3).